|

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

RECRUITINGN/ASponsored by Emory University
Actively Recruiting
PhaseN/A
SponsorEmory University
Started2025-10-15
Est. completion2026-09-17
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT07213154

Summary

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or Female
* Candidate with skin lesions
* Signed study-specific informed consent prior to study entry
* ≥ 18 years old

Exclusion Criteria:

* Prior surgery or radiotherapy to the area to be treated

Conditions4

CancerMalignant Skin NeoplasmSkin DisorderSkin Neoplasm

Locations2 sites

Emory University Hospital Midtown
Atlanta, Georgia, 30308
Tiffaney Roundtreetiffaney.laquinta.roundtree@emory.edu
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322
Tiffaney K. Roundtreetiffaney.laquinta.roundtree@emory.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.